Olink Holding AB (publ)
F:6XA
Olink Holding AB (publ)
F:6XA
Price:
24
EUR
1.69%
Market Closed
Market Cap:
€3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Olink Holding AB (publ)
F:6XA
|
SE |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 6XA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6XA
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
6XA Competitors Multiples
Olink Holding AB (publ) Competitors
Olink Holding AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Olink Holding AB (publ)
F:6XA
|
3B EUR | 20.6 | -104.6 | -90.9 | -59.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
975.8B USD | 341.7 | 4 045.6 | 1 159.2 | 2 232.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.9B USD | 4.1 | 27.6 | 19.2 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
135.1B USD | 5.5 | 37.4 | 19 | 27.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
307.9B CNY | 6.8 | 16.1 | 16.8 | 16.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.2B CHF | 5.4 | 37.1 | 27.6 | 27.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.6B USD | 4.6 | 25.3 | 18.6 | 22 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.8B USD | 9.4 | 46.4 | 30 | 37.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.4B USD | 1.8 | 21.7 | 12 | 18 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.7B USD | 6.4 | 29.5 | 21.9 | 24.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
